Indirect Treatment Comparison of Daratumumab, Pomalidomide, and Dexamethasone Versus Standard of Care in Patients with Difficult-To-Treat Relapsed/Refractory Multiple Myeloma
AuthID
P-00W-YQH
P-00W-YQH